[ BiovelocITA raises $7.2M in Series A ]
BiovelocITA has raised $7.2 million in Series A funding.
Founded in 2015, BiovelocITA is an accelerator dedicated to supporting the launch and growth of biotech companies by bringing together scientists, entrepreneurs and investors.
The organization aims to accelerate to proof of concept promising research projects and transform them into biotech companies.
Overall this is one of the largest collections of the last two years for an Italian start-up.
|Founder / CEO||Gabriella Camboni|
|Banor Sim S.p.A|
|Previous Investors||Atlante Seed|